Cleared Traditional

K132463 - CIANNA MEDICAL PERMANENT TISSUE MARKER ...

K132463 is an FDA 510(k) clearance for CIANNA MEDICAL PERMANENT TISSUE MARKER ..., manufactured by Cianna Medical, Inc.. The device is a Class 2 General & Plastic Surgery device with product code NEU cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K132463 · Cianna Medical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2013
Decision
118d
Days
Class 2
Risk

K132463 is an FDA 510(k) clearance for the CIANNA MEDICAL PERMANENT TISSUE MARKER AND DELIVERY SYSTEM. Classified as Marker, Radiographic, Implantable (product code NEU), Class II - Special Controls.

Submitted by Cianna Medical, Inc. (Aliso Viejo, US). The FDA issued a Cleared decision on December 3, 2013 after a review of 118 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4300 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Cianna Medical, Inc. devices

FDA 510(k) Submission Details - K132463

510(k) Number K132463 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 2013
Decision Date December 03, 2013
Days to Decision 118 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 115d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NEU Device Classification - Class 2, Special Controls

Product Code NEU Marker, Radiographic, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NEU Marker, Radiographic, Implantable

All 65
Devices cleared under the same product code (NEU) and FDA review panel - the closest regulatory comparables to K132463.
CAREFUSION GOLD TISSUE MARKER
K141722 · Care Fusion · Jan 2015
BNX Fine Needle Aspiration System
K142198 · Covidien, LLC · Oct 2014
ECHO TIP ULTRA FIDUCIAL NEEDLE
K141356 · Wilson-Cook Medical, Inc. · Jun 2014
STARCHMARK BREAST TISSUE MARKER
K131654 · Senorx, Inc. · Jun 2013
SENOMARK ULTRA BREAST TISSUE MARKER
K123911 · C.R. Bard, Inc. · Jan 2013
SECRMARK BIOPSY SITE MARKING SYSTEM
K102768 · Hologic, Inc. · Dec 2010